← Back
Data updated: Mar 29, 2026
CELLTRION INC
ImmunologyOncologyGastroenterology
Biotech
CELLTRION INC is a biotechnology company focused on Immunology, Oncology, Gastroenterology.
2016
Since
11
Drugs
-
Trials
20
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 45%
5 drugs Phase 3: 11 Phase 1: 2
Oncology 27%
5 drugs Phase 3: 4
Gastroenterology 19%
4 drugs Phase 3: 1 Phase 2: 1 Phase 1: 2
Ophthalmology 6%
1 drugs Phase 3: 1
Respiratory 4%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Novartis big-pharma
Oncology, Immunology, Ophthalmology, Respiratory
Roche big-pharma
Oncology, Ophthalmology, Immunology, Respiratory
Pfizer big-pharma
Oncology, Immunology, Gastroenterology
AbbVie big-pharma
Immunology, Oncology, Ophthalmology
Gilead Sciences biotech
Oncology, Immunology, Gastroenterology, Respiratory